Načítá se...
Chloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19
The proposed doses of chloroquine (CQ) and hydroxychloroquine (HCQ) for treatment of COVID-19 (1000 mg/day for 10 days, CQ; 800 mg first day then 400 mg/day for 5 days, HCQ) in many guidelines worldwide, are considerably higher than the maximum recommended daily safe doses of both agents (≤2.3 mg/kg...
Uloženo v:
| Vydáno v: | Asia Pac J Ophthalmol (Phila) |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7227199/ https://ncbi.nlm.nih.gov/pubmed/32349115 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/APO.0000000000000289 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|